Opko Health, Inc. to Present at the Jefferies and Co. 2013 Global Healthcare Conference
5/30/2013 8:08:48 AM
More...
|
Opko Health, Inc. Surpasses 50% Enrollment in First Phase 3 Trial of Rayaldy™ (CTAP101 Capsules)
5/23/2013 11:10:03 AM
More...
|
Opko Health, Inc. Acquires PROLOR Biotech (PBTH) for $480 Million
4/24/2013 7:37:46 AM
More...
|
RXi Pharmaceuticals (RXII) Raises a Gross $16.4 Million in a Private Placement Led by Opko Health, Inc.
3/7/2013 7:28:57 AM
More...
|
Opko Health, Inc. Closes Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033
1/31/2013 10:18:52 AM
More...
|
Opko Health, Inc. Prices Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033
1/25/2013 9:03:56 AM
More...
|
Opko Health, Inc. to Acquire Privately Held Cytochroma Inc.
1/9/2013 9:03:05 AM
More...
|
Opko Health, Inc. to Expand Latin American Presence With Acquisition of Brazilian Pharmaceutical Company
12/27/2012 9:19:52 AM
More...
|
Opko Health, Inc. Completes Acquisition of CLIA Laboratory
12/18/2012 9:08:56 AM
More...
|
Opko Health, Inc. to Buy Clinical Laboratory Company for $40 Million Biz
10/19/2012 7:57:08 AM
More...
|
|